Santen Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 28, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	616,176	574,345	484,047	559,190	424,342	490,898
Market Cap Growth	24.74%	18.66%	-13.44%	31.78%	-13.56%	-19.37%
Enterprise Value	534,329	511,855	405,379	476,424	362,459	422,435
Last Close Price	1915.50	1785.50	1386.62	1469.04	1056.18	1112.09
PE Ratio	16.83	15.37	13.35	21.00	-	18.04
Forward PE	16.38	16.06	14.12	17.09	25.03	16.26
PS Ratio	2.11	1.97	1.61	1.85	1.52	1.84
PB Ratio	2.08	1.94	1.70	1.83	1.45	1.46
P/TBV Ratio	2.73	2.55	2.30	2.52	2.15	2.37
P/FCF Ratio	16.81	15.67	8.92	8.83	21.36	17.11
P/OCF Ratio	14.16	13.20	7.95	7.70	11.42	10.66
PEG Ratio	3.11	2.79	2.79	2.79	2.79	2.79
EV/Sales Ratio	1.83	1.76	1.35	1.58	1.30	1.59
EV/EBITDA Ratio	8.08	7.74	6.12	6.77	6.90	7.98
EV/EBIT Ratio	11.18	10.71	8.39	9.13	10.27	11.78
EV/FCF Ratio	14.58	13.96	7.47	7.52	18.24	14.72
Debt / Equity Ratio	-	-	0.12	0.11	0.12	0.10
Debt / EBITDA Ratio	-	-	0.52	0.49	0.69	0.62
Debt / FCF Ratio	-	-	0.63	0.55	1.82	1.15
Net Debt / Equity Ratio	-0.27	-0.27	-0.21	-0.20	-0.07	-0.15
Net Debt / EBITDA Ratio	-1.22	-1.22	-0.89	-0.85	-0.41	-0.95
Net Debt / FCF Ratio	-2.21	-2.21	-1.08	-0.95	-1.09	-1.74
Asset Turnover	0.70	0.70	0.71	0.71	0.63	0.62
Inventory Turnover	2.10	2.10	2.72	2.99	2.95	2.79
Quick Ratio	1.74	1.74	1.90	2.00	1.85	1.91
Current Ratio	2.60	2.60	2.58	2.55	2.38	2.39
Return on Equity (ROE)	12.93%	12.93%	12.14%	8.92%	-4.75%	8.45%
Return on Assets (ROA)	7.18%	7.18%	7.14%	7.61%	5.01%	5.20%
Return on Invested Capital (ROIC)	17.36%	17.14%	15.46%	18.05%	12.64%	10.12%
Return on Capital Employed (ROCE)	14.30%	14.30%	15.00%	15.20%	10.60%	9.90%
Earnings Yield	6.06%	6.51%	7.49%	4.76%	-3.52%	5.54%
FCF Yield	5.95%	6.38%	11.21%	11.33%	4.68%	5.85%
Dividend Yield	1.98%	-	2.60%	2.25%	3.03%	2.88%
Payout Ratio	33.83%	33.83%	33.40%	44.59%	-	44.07%
Buyback Yield / Dilution	6.10%	6.10%	5.01%	4.98%	3.26%	-0.02%
Total Shareholder Return	8.11%	6.10%	7.61%	7.22%	6.29%	2.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.